Geovax

Developer of human vaccines for cancer and infectious diseases

placeSmyrna, Georgia, United States calendar_todayFounded 1988 groups17 employees language geovax.com

Registered entities

Innovation

18 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 2,069 times.

YearFilings
20151
20162
20175
20184
20198
20205
20216
20229
20235
20247
20254
20261

Social engagement

Social engagement: 3.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Bank & private debt120%
Other / undisclosed360%

Recent activity

29 Jun 2026
Product launch
Gedeptin® program
22 Jun 2026
Event
BIO2026
18 Jun 2026
Event
BIO2026
Coming soon